Cellnovo announces the registration of its document de base in the context of its planned IPO on the regulated market of Euronext in Paris

Cellnovo Group ("Cellnovo"), a medical technology company that has developed and markets the first connected all-in-one diabetes management system, announces the registration of its document de base with the Autorité des Marchés Financiers (AMF), under number I.15-008 on February 27, 2015.